The DOI matches its Crossref record; 1,858 of the 1,862 references it cites were found in a registry or an index.
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Open accessAbstract
This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell-derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








![Fig. 9 Antiproteolytic effect of acetaldehyde in the single pass perfused rat liver. a Acetaldehyde (5 mmol/l) was infused into the perfused liver for 30 min, and the release of [3H]leucine from pre-labeled rats was taken as a measure of proteolysis. b The resulting inhibition of proteolysis under steady-state conditions at different concentrations of acetaldehyde. Data are from 2 to 4 different experiments and are given as mean ± SEM. From vom Dahl and Häussinger (1998)](/paper-figures/2844bb4a493e46429af445399835e22f/recent-advances-in-2d-and-3d-in-vitro-systems-using-primary-hepatocytes-figure-9.jpg)
















































Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Already in the first few days of cultivation, a reduction of hepatic functions can be observed, e.g. production of plasma proteins, drug metabolizing enzyme activities, glucose metabolism and urea synthesis (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary human hepatocytes (PHHs) are an important tool for studying human liver disease and drug-induced liver injury (DILI), with other models, such as rat hepatocytes, hepatic cell lines and stem cell-derived hepatocyte-like cells failing to offer metabolically competent and species-relevant alternatives (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, zonation appears to be a large influencing factor on variation during culture as our pathway analysis of the most variable proteins revealed significant association with ketogenesis, cholesterol biosynthesis, fatty acid β oxidation and glutamine synthesis (table S4), all of these are related to the portocentral axis gradient of the lobule (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“although cytotoxicity measures are fundamental in the assessment of a drug’s potential for hepatotoxicity in vitro33,34, gene expression and various phenotypic changes can occur at much lower concentrations35,36.”
From Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology (2022) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“The apical membrane is equipped with transport proteins that eliminate bile acids and xenobiotics from the cell, like multidrug resistance-associated protein 2 (MRP2) (Godoy et al., 2013[15]; Ito et al., 2005[20]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The hepatocyte's basal membrane faces the sinusoid. It expresses several transmembrane transporters that manage the exchange of substances with the sinusoidal blood stream (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“In vivo, the distribution of ECM components varies between the different parts of the liver acinus, the smallest organizational unit of the liver (Godoy et al., 2013[15]; Martinez-Hernandez and Amenta, 1993[26]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In practice, strategies for optimizing HepG2 can be divided into several approaches. The first approach is based on genetic modification of cells to express key biotransformation enzymes, in particular cytochrome P450 isoforms [109]. The second approach involves epigenetic and cultural maturation of cells, which allows for increased expression of nuclear receptors and, consequently, of xenobiotic”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [163]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Wheat proteins improve cryopreservation of rat hepatocytes
Grondin, M., Hamel, F., Averill‐Bates, D. A., & Sarhan, F. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22270 · Cited by 18
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Computer Simulation of Liquids
Allen, M. P., & Tildesley, D. J. (2017) · doi:10.1093/oso/9780198803195.001.0001 · Cited by 20,945
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Computer Simulation of Liquids
P, S., & J, K. (1988) · Journal of Molecular Liquids · doi:10.1016/0167-7322(88)80022-9 · Cited by 16,088
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Two-photon laser scanning fluorescence microscopy
Denk, W., Strickler, J. H., & Webb, W. W. (1990) · Science · doi:10.1126/science.2321027 · Cited by 9,488
Research works printed but not linked: 9
- Bode JG (2011) Inflammation and liver regeneration. In: Häussinger D (ed) Liver regneration. DeGruyter Verlag, Berlin
- Bücher T, Sies H (1976) Mitochondrial and cytosolic redox states in perfused rat liver: methods and problems in metabolic compartmentation. In: Tager jm WJ, Söling D (eds) Use of isolated liver cells and kidney tubules in metabolic studies. North Holland Publishing Company/American Elsevier, New York/Amsterdam
- EPA (2012) EPA’s reanalysis of key issues related to dioxin toxicity and response to NAS Comments. Environmental Protection Agency (EPA), Washington, DC
- Hallifax D, Foster JA, Houston JB (2010) Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res 27:2150–2161 · DOI
- ITC (International Transporter Consortium) (2010) Membrane transporters in drug development (Report from the FDA Critical Path Workshop). Nat Rev Drug Discov 9:215–236 · DOI · Paper page
- Lamers W, Moorman A, Charles R (1989) The metabolic lobulus, a key to the architecture of the liver. In: Revisiones Sobre Biologia Celular, Springer, New York
- Sahin S (2003) Perfused liver preparation and its applications. FABAD J Pharm Sci 28:39–49
- Waddington CH (1942) The epigenotype. Endeavour 1:18–20
- Warburg O (1923) Versuche an überlebendem Karzinomgewebe. Biochem Z 142:317
Cited by
Sorted by citations
Items 501–600 of 1,002
Machine Perfusion of the Liver: Applications Beyond Transplantation
Hefler, J., Marfil‐Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2020) · Transplantation · doi:10.1097/tp.0000000000003320 · Cited by 23
Creating rat hepatocyte organoid as an in vitro model for drug testing
He, Y.-T., Zhu, X.-L., Li, S.-F., Zhang, B.-Q., Li, Y., Wu, Q., Zhang, Y.-L., Zhou, Y.-Y., Li, L., Qi, Y.-N., et al. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i10.1184 · Cited by 22
The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development
Zhou, Z., Zhu, J., Jiang, M., Sang, L., Hao, K., & He, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050704 · Cited by 23
Parmentier, Y., Pothier, C., Hewitt, N. J., Vincent, L., Caradec, F., Liu, J., Lin, F., Trancart, M.-M., Guillet, F., Bouaita, B., et al. (2018) · Xenobiotica · doi:10.1080/00498254.2017.1422156 · Cited by 22
Self-citationMicroscale 3D Liver Bioreactor for In Vitro Hepatotoxicity Testing under Perfusion Conditions
Freyer, N., Greuel, S., Knöspel, F., Gerstmann, F., Storch, L., Damm, G., Seehofer, D., Harris, J. F., Iyer, R. S., Schubert, F., et al. (2018) · Bioengineering · doi:10.3390/bioengineering5010024 · Cited by 24
Self-citationIn vitro systems: current limitations and future perspectives
Ghallab, A., & Bolt, H. M. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1404-6 · Cited by 22
Wang, Y., Lee, J.-H., Shirahama, H., Seo, J., Glenn, J. S., & Cho, N.-J. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00487 · Cited by 21
Organoids: Principle, application and perspective
Liu, K., Fang, X., Aazmi, A., Wang, Q., Gong, X., Chen, Z., Qin, M., Pu, C., Zhao, Y., Qiu, X., et al. (2024) · The Innovation Life · doi:10.59717/j.xinn-life.2024.100088 · Cited by 21
Hepatocyte size fractionation allows dissection of human liver zonation
Ölander, M., Wegler, C., Flörkemeier, I., Treyer, A., Handin, N., Pedersen, J. M., Vildhede, A. M., Mateus, A., LeCluyse, E. L., Urdzik, J., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30273 · Cited by 22
Self-citationHammour, M. M., Othman, A., Aspera-Werz, R. H., Braun, B., Weis-Klemm, M., Wagner, S., Nadalin, S., Histing, T., Ruoß, M., & Nussler, A. K. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03329-8 · Cited by 21
Self-citationVascularized pancreas-on-a-chip device produced using a printable simulated extracellular matrix
Hospodiuk-Karwowski, M., Chi, K., Pritchard, J. R., & Catchmark, J. M. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac8c74 · Cited by 21
Dichamp, J., Cellière, G., Ghallab, A., Hassan, R. A. R. A., Boissier, N., Hofmann, U., Reinders, J., Sezgin, S., Zühlke, S., Hengstler, J. G., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1049564 · Cited by 21
Self-citationComplex in vitro models positioned for impact to drug testing in pharma: a review
Kang, S., Chen, E. C., Cifuentes, H., Co, J. Y., Cole, G., Graham, J. C., Hsia, I., Kiyota, T., Klein, J. A., Kroll, K. T., et al. (2024) · Biofabrication · doi:10.1088/1758-5090/ad6933 · Cited by 22
Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects
Singh, S., Srivastava, A., Kumar, V., Pandey, A., Kumar, D., Rajpurohit, C. S., Khanna, V. K., Yadav, S., & Pant, A. B. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9615-2 · Cited by 21
Satoh, D., Iwado, S., Abe, S., Kazuki, K., Wakuri, S., Oshimura, M., & Kazuki, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187072 · Cited by 21
Kiamehr, M., Alexanova, A., Viiri, L. E., Heiskanen, L., Vihervaara, T., Kauhanen, D., Ekroos, K., Laaksonen, R., Käkelä, R., & Aalto‐Setälä, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27131 · Cited by 21
Numerical Investigations of Hepatic Spheroids Metabolic Reactions in a Perfusion Bioreactor
Sharifi, F., Firoozabadi, B., & Firoozbakhsh, K. K. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00221 · Cited by 21
Recent advances in the development of in vitro liver models for hepatotoxicity testing
Lu, S., Zhang, J., Lin, S., Zheng, D., Shen, Y., Qin, J., Li, Y. Y., & Wang, S. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00142-7 · Cited by 21
Yan, X., Zhuo, Y., Bian, X., Li, J., Zhang, Y., Ma, L., Lu, G., Guo, M., Wu, J., & Li, N. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00350 · Cited by 21
The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
Ghallab, A. (2014) · Europe PMC (PubMed Central) · doi:10.17877/de290r-7430 · Cited by 20
Advancing hepatotoxicity assessment: current advances and future directions
Kim, Y., Kim, Y., & Kim, Y. (2025) · Toxicological Research · doi:10.1007/s43188-025-00289-w · Cited by 22
Hepatic organoids as a platform for liver disease modeling and the development of novel therapies
Luce, E., Messina, A., & Duclos‐Vallée, J. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102647 · Cited by 23
Creation of Three-Dimensional Liver Tissue Models from Experimental Images for Systems Medicine
Hoehme, S., Friebel, A., Hammad, S., Drasdo, D., & Hengstler, J. G. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6506-9_22 · Cited by 20
Self-citationHeintze, T., Klein, K., Hofmann, U., & Zanger, U. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79952-1 · Cited by 20
Hepatocyte cultures: From collagen gel sandwiches to microfluidic devices with integrated biosensors
de Hoyos‐Vega, J. M., Hong, H. J., Stybayeva, G., & Revzin, A. (2021) · APL Bioengineering · doi:10.1063/5.0058798 · Cited by 21
In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 21
Saran, C., Fu, D., Ho, H. S. S., Klein, A., Fallon, J. K., Honkakoski, P., & Brouwer, K. L. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-18174-z · Cited by 20
Toward 3D‐Bioprinted Models of the Liver to Boost Drug Development
Guagliano, G., Volpini, C., Vangosa, F. B., Cornaglia, A. I., Visai, L., & Petrini, P. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200264 · Cited by 21
Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures
Suominen, S., Hyypijev, T., Venäläinen, M., Yrjänäinen, A., Vuorenpää, H., Lehti-Polojärvi, M., Räsänen, M., Seppänen, A., Hyttinen, J., Miettinen, S., et al. (2023) · Cells · doi:10.3390/cells12192368 · Cited by 20
Transgenic Zebrafish Reporter Lines as AlternativeIn VivoOrgan Toxicity Models
Poon, K. L., Wang, X., Lee, S. G. P., Ng, A. S. M., Goh, W. H., Zhao, Z., Al‐Haddawi, M., Wang, H., Mathavan, S., Ingham, P. W., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw250 · Cited by 20
Orbach, S. M., Ehrich, M. F., & Rajagopalan, P. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.05.006 · Cited by 20
Malinen, M. M., Ito, K., Kang, H. E., Honkakoski, P., & Brouwer, K. L. R. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.01.022 · Cited by 22
Self-citationBlau, B. J., & Miki, T. (2019) · Differentiation · doi:10.1016/j.diff.2019.02.006 · Cited by 20
Bale, S. S., Manoppo, A., Thompson, R. L., Markoski, A., Coppeta, J. R., Cain, B. P., Haroutunian, N. J., Newlin, V., Spencer, A., Azizgolshani, H., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26986 · Cited by 20
Correlation between serum 25‑OH vitamin D expression and non‑alcoholic fatty liver disease
Cai, J., Zhang, Z., Liu, J., Xiao, X., Wang, C., Deng, M., & Chen, L. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8411 · Cited by 20
Sphabmixay, P., Raredon, M. S. B., Wang, A. J.-S., Lee, H., Hammond, P. T., Fang, N. X., & Griffith, L. G. (2021) · Biofabrication · doi:10.1088/1758-5090/ac23aa · Cited by 20
Innovation for hepatotoxicity in vitro research models: A review
Han, W., Wu, Q., Zhang, X., & Duan, Z. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3711 · Cited by 22
Bioprinted high cell density liver model with improved hepatic metabolic functions
Lu, T.-Y., Ji, Y., Lyu, C., Shen, E. N., Sun, Y., Xiang, Y., Meng‐Saccoccio, T., Feng, G., & Chen, S. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123256 · Cited by 19
Unraveling liver complexity from molecular to organ level: Challenges and perspectives
D'Alessandro, L. A., Hoehme, S., HENNEY, A. M., Drasdo, D., & Klingmüller, U. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.11.005 · Cited by 21
Self-citationKonagaya, S., & Iwata, H. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.05.012 · Cited by 19
Donato, M. T., Gómez-Lechón, M. J., & Tolosa, L. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1271784 · Cited by 20
Self-citationA new cell-sized support for 3D cell cultures based on recombinant spider silk fibers
Stern-Tal, D., Ittah, S., & Sklan, E. (2021) · Journal of Biomaterials Applications · doi:10.1177/08853282211037781 · Cited by 19
Hewitt, N. J., Troutman, J. A., Przibilla, J., Schepky, A. G., Ouédraogo, G., Mahony, C., Kenna, J. G., Varçin, M., & Dent, M. (2022) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2022.105132 · Cited by 20
Self-citationNell, P., Kattler, K., Feuerborn, D., Hellwig, B., Rieck, A., Salhab, A., Lepikhov, K., Gasparoni, G., Thomitzek, A., Belgasmi, K., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.009 · Cited by 19
Self-citationLim, A. Y., Kato, Y., Sakolish, C., Valdiviezo, A., Han, G., Bajaj, P., Stanko, J. P., Ferguson, S., Villenave, R., Hewitt, P. G., et al. (2023) · Bioengineering · doi:10.3390/bioengineering10101195 · Cited by 19
Self-citationA shift in paradigm towards human biology‐based systems for cholestatic‐liver diseases
Noor, F. (2015) · The Journal of Physiology · doi:10.1113/jp271124 · Cited by 19
Yasunaga, M., Fujita, Y., Saito, R., Oshimura, M., & Nakajima, Y. (2017) · BMC Biotechnology · doi:10.1186/s12896-017-0374-1 · Cited by 19
Lin, C., Romero, R., Sorokina, L. V., Ballinger, K. R., Place, L. W., Kipper, M. J., & Khetani, S. R. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36293 · Cited by 19
Microfabrication of liver and heart tissues for drug development
Brown, G. E., & Khetani, S. R. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0225 · Cited by 19
Perfused Organ Cell‐Dense Macrotissues Assembled from Prefabricated Living Microtissues
Ip, B. C., Cui, F. R., Wilks, B. T., Murphy, J., Tripathi, A., & Morgan, J. R. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800076 · Cited by 19
Effect of glucose and insulin supplementation on the isolation of primary human hepatocytes
Damm, G., Schicht, G., Zimmermann, A., Körner, C., Fischer, N., Kießig, M., Wagner, T. C., Kegel, V., & Seehofer, D. (2019) · EXCLI journal · doi:10.17179/excli2019-1782 · Cited by 20
Self-citationTasnim, F., Singh, N. H., Tan, E. K. F., Xing, J., Li, H., Hissette, S., Manesh, S., Fulwood, J., Gupta, K., Ng, C. W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61699-4 · Cited by 19
Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects
Dame, K., & Ribeiro, A. J. S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220959598 · Cited by 19
Pulsed Microfluid Force-Based On-Chip Modular Fabrication for Liver Lobule-Like 3D Cellular Models
Cui, J., Wang, H., Shi, Q., & Sun, T. (2021) · Cyborg and Bionic Systems · doi:10.34133/2021/9871396 · Cited by 19
HepaRG Maturation in Silk Fibroin Scaffolds: Toward Developing a 3D In Vitro Liver Model
Abbott, A., & Coburn, J. M. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01584 · Cited by 19
Wojdyła, K., Wrzesinski, K., Williamson, J. C., Fey, S. J., & Rogowska-Wrzesińska, A. (2016) · Toxicology Research · doi:10.1039/c5tx00469a · Cited by 19
Raška, J., Čtveráčková, L., Dydowiczová, A., Sovadinová, I., Bláha, L., & Babica, P. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.03.011 · Cited by 19
The body-on-a-chip concept: possibilities and limitations
Reif, R. (2014) · Europe PMC (PubMed Central) · doi:10.17877/de290r-7275 · Cited by 18
Liver regeneration biology: Implications for liver tumour therapies
Hadjittofi, C., Feretis, M., Martin, J. L., Harper, S., & Huguet, E. (2021) · World Journal of Clinical Oncology · doi:10.5306/wjco.v12.i12.1101 · Cited by 18
Sasikumar, S., Chameettachal, S., Kingshott, P., Cromer, B., & Pati, F. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00994 · Cited by 18
Stavropoulos, A., Divolis, G., Manioudaki, M., Gavriil, A., Kloukina, I., Perrea, D. N., Sountoulidis, A., Ford, E., Doulou, A., Apostolidou, A. C., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abn4395 · Cited by 18
Sanchez-Quant, E., Richter, M., Martinez‐Jimenez, C. P., & Colomé‐Tatché, M. (2022) · Genome biology · doi:10.1016/s0168-8278(22)01138-2 · Cited by 18
Chen, M., Wu, G., Lu, Y., Sun, S., Zhao, Y., Pan, X., Chen, W., Xu, J., Qiu, H., He, W., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.002 · Cited by 18
Self-citationIn vitro hepatic 3D cell models and their application in genetic toxicology: A systematic review
Štampar, M., & Žegura, B. (2024) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2024.503835 · Cited by 18
Kim, H., & Park, H. (2025) · Toxicological Research · doi:10.1007/s43188-024-00275-8 · Cited by 18
ESNATS Conference — The use of Human Embryonic Stem Cells for Novel Toxicity Testing Approaches
Rovida, C., Vivier, M., Garthoff, B., & Hescheler, J. (2014) · Alternatives to Laboratory Animals · doi:10.1177/026119291404200203 · Cited by 18
Carbonell, P. (2016) · ALTEX · doi:10.14573/altex.1602071 · Cited by 18
Stieger, B., & Mahdi, Z. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.023 · Cited by 19
Self-citationGuo, X., Li, W., Ma, M., Lü, X., & Zhang, H. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13195 · Cited by 18
Non-hemorrhage-related adverse effects of rivaroxaban
Christopoulou, E. C., Filippatos, T. D., & Elisaf, M. (2017) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2017.72533 · Cited by 19
Bioinspired liver scaffold design criteria
Mattei, G., Magliaro, C., Pirone, A., & Ahluwalia, A. D. (2018) · Organogenesis · doi:10.1080/15476278.2018.1505137 · Cited by 18
Long‐term maintenance of functional primary human hepatocytes using small molecules
Katsuda, T., Kawamata, M., Inoue, A., Yamaguchi, T., Abe, M., & Ochiya, T. (2019) · FEBS Letters · doi:10.1002/1873-3468.13582 · Cited by 20
Lee, H., Ahn, J., Jung, C., Jeung, Y. S., Cho, H., Son, M. J., & Chung, K. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27328 · Cited by 18
Zhuang, T., Li, X., Deng, Q., Zhao, W., Lin, B., Luo, Y., & Zhang, X. (2020) · Materials Letters · doi:10.1016/j.matlet.2020.128034 · Cited by 18
Transcriptome-wide organization of subcellular microenvironments revealed by ATLAS-Seq
Adekunle, D. A., & Wang, E. T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa334 · Cited by 18
Sibanda, T. Z., O’Shea, C. J., Vilela, J. D. S., Kolakshyapati, M., Welch, M., Schneider, D. A., Courtice, J. M., & Ruhnke, I. (2020) · Animals · doi:10.3390/ani10101911 · Cited by 18
Davidson, M. D., Pickrell, J., & Khetani, S. R. (2020) · Toxicology · doi:10.1016/j.tox.2020.152662 · Cited by 18
Dagur, R. S., New‐Aaron, M., Ganesan, M., Wang, W., Romanova, S., Kidambi, S., Kharbanda, K. K., Poluektova, L. Y., & Osna, N. A. (2021) · Biology · doi:10.3390/biology10010029 · Cited by 18
Tutty, M. A., Vella, G., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01170-1 · Cited by 19
Sarkar, J., Kumari, J., Tonello, J. M., Kamihira, M., & Kumar, A. (2017) · Biotechnology Journal · doi:10.1002/biot.201700274 · Cited by 18
The Efficacy of the Hepatocyte Spheroids for Hepatocyte Transplantation
Shibuya, K., Watanabe, M., Goto, R., Zaitsu, M., Ganchiku, Y., & Taketomi, A. (2021) · Cell Transplantation · doi:10.1177/09636897211000014 · Cited by 18
Säll, C., Alifrangis, L., Dahl, K., Friedrichsen, M. H., Nygård, S. B., & Kristensen, K. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000865 · Cited by 17
Advances and applications of organ-on-a-chip technology
Kong, J. S., Kim, J., Jang, J., & Cho, D.-W. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101361 · Cited by 17
Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity
Stoeber, R. (2016) · EXCLI journal · doi:10.17179/excli2016-864 · Cited by 17
In Vitro Hepatic Models to Assess Herb–Drug Interactions: Approaches and Challenges
Hlengwa, N., Masilela, C. M., Mtambo, T. R., Sithole, S., Naidoo, S., Machaba, K. E., Shabalala, S. C., Ntamo, Y., Dludla, P. V., & Milase, R. N. (2023) · Pharmaceuticals · doi:10.3390/ph16030409 · Cited by 17
Ming, Z., Tang, X., Liu, J., & Ruan, B. (2023) · Molecules · doi:10.3390/molecules28093683 · Cited by 17
Sani, F., Zomorrod, M. S., Azarpira, N., & Soleimani, M. (2023) · Stem Cells International · doi:10.1155/2023/8836452 · Cited by 17
RetractedRogozhnikov, D., Luo, W., Elahipanah, S., O’Brien, P. J., & Yousaf, M. N. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00187 · Cited by 17
Lancett, P., Williamson, B., Barton, P., & Riley, R. J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081596 · Cited by 17
Impact of Percoll purification on isolation of primary human hepatocytes
Horner, R., Gassner, J. G. M. V., Kluge, M., Tang, P., Lippert, S., Hillebrandt, K. H., Moosburner, S., Reutzel‐Selke, A., Pratschke, J., Sauer, I. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43042-8 · Cited by 19
Controlled Functional Zonation of Hepatocytes In Vitro by Engineering of Wnt Signaling
Wahlicht, T., Vièyres, G., Bruns, S. A., Meumann, N., Büning, H., Häuser, H., Schmitz, I., Pietschmann, T., & Wirth, D. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00435 · Cited by 17
Ganesan, M., Mathews, S., Makarov, E., Petrosyan, A., Kharbanda, K. K., Kidambi, S., Poluektova, L. Y., Casey, C. A., & Osna, N. A. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00109.2020 · Cited by 17
Will Advances in Preclinical In Vitro Models Lower the Costs of Drug Development?
Visk, D. (2015) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.1503 · Cited by 17
Functionality based method for simultaneous isolation of rodent hepatic sinusoidal cells
Stradiot, L., Verhulst, S., Roosens, T., Øie, C. I., Moya, I. M., Halder, G. A., Mannaerts, I., & van Grunsven, L. A. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.047 · Cited by 17
Drugs of abuse from a different toxicological perspective: an updated review of cocaine genotoxicity
Oliveira, N., & Dinis‐Oliveira, R. J. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2281-1 · Cited by 17
Liu, Q., Wang, X., & Xia, T. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1289-y · Cited by 17
Böttger, J., Arnold, K., Thiel, C., Körner, C., Aleithe, S., Hofmann, U., Vlaic, S., Sales, S., Shevchenko, A., & Matz‐Soja, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1571-0 · Cited by 18
Self-citationAbdel‐Wareth, A. A. A., Hammad, S., & Ahmed, H. (2014) · Europe PMC (PubMed Central) · doi:10.17877/de290r-15999 · Cited by 17
Self-citationKhetani, S. R. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.12.005 · Cited by 17
Negoro, R., Tasaka, M., Deguchi, S., Takayama, K., & Fujita, T. (2022) · Cells · doi:10.3390/cells11101677 · Cited by 16
Metadata
- Authors
- Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., Braeuning, A., Budinsky, R. A., Burkhardt, B., Cameron, N. R., Camussi, G., Cho, C.-S., Choi, Y.-J., Craig Rowlands, J., Dahmen, U., Damm, G., Dirsch, O., Donato, M. T., Dong, J., Dooley, S., Drasdo, D., Eakins, R., Ferreira, K. S., Fonsato, V., Fraczek, J., Gebhardt, R., Gibson, A., Glanemann, M., Goldring, C. E. P., Gómez-Lechón, M. J., Groothuis, G. M. M., Gustavsson, L., Guyot, C., Hallifax, D., Hammad, S., Hayward, A., Häussinger, D., Hellerbrand, C., Hewitt, P., Hoehme, S., Holzhütter, H.-G., Houston, J. B., Hrach, J., Ito, K., Jaeschke, H., Keitel, V., Kelm, J. M., Kevin Park, B., Kordes, C., Kullak-Ublick, G. A., LeCluyse, E. L., Lu, P., Luebke-Wheeler, J., Lutz, A., Maltman, D. J., Matz-Soja, M., McMullen, P., Merfort, I., Messner, S., Meyer, C., Mwinyi, J., Naisbitt, D. J., Nussler, A. K., Olinga, P., Pampaloni, F., Pi, J., Pluta, L., Przyborski, S. A., Ramachandran, A., Rogiers, V., Rowe, C., Schelcher, C., Schmich, K., Schwarz, M., Singh, B., Stelzer, E. H. K., Stieger, B., Stöber, R., Sugiyama, Y., Tetta, C., Thasler, W. E., Vanhaecke, T., Vinken, M., Weiss, T. S., Widera, A., Woods, C. G., Xu, J. J., Yarborough, K. M., & Hengstler, J. G.
- Affiliations
- University of Zurich (CH)
- Leibniz Research Centre for Working Environment and Human Factors (DE)
- The Hamner Institutes for Health Sciences (US)
- Goethe University Frankfurt (DE)
- Vrije Universiteit Brussel (BE)
- University of Freiburg (DE)
- Leipzig University (DE)
- Dow Chemical (United States) (US)
- Durham University (GB)
- Seoul National University (KR)
- Instituto de Investigación Sanitaria La Fe (ES)
- Heidelberg University (DE)
- University of Liverpool (GB)
- University of Groningen (NL)
- Lund University (SE)
- University of Manchester (GB)
- South Valley University (EG)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Regensburg (DE)
- Merck KGaA, Darmstadt (Germany) (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Musashino University (JP)
- University Hospital Zurich (CH)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Hewitt, Nicola J.
- ORCID
- Hewitt, Nicola J.
- Andersen, Melvin E.
- Bhattacharya, Sudin
- Bode, Johannes Georg
- Borner, Christoph
- Böttger, Jan
- Braeuning, Albert
- Budinsky, Robert A.
- Cameron, Neil R.
- Camussi, Giovanni
- Cho, Chong-Su
- Choi, Yun-Jaie
- Dahmen, Uta
- Damm, Georg
- Dirsch, Olaf
- Donato, María Teresa
- Dong, Jian
- Dooley, Steven
- Drasdo, Dirk
- Gibson, Andrew
- Glanemann, Matthias
- Groothuis, Geny M. M.
- Hallifax, David
- Hammad, Seddik
- Hayward, Adam
- Häussinger, Dieter
- Hellerbrand, Claus
- Hewitt, Philip
- Hoehme, Stefan
- Holzhütter, Hermann-Georg
- Houston, J. Brian
- Ito, Kiyomi
- Jaeschke, Hartmut
- Keitel, Verena
- Kordes, Claus
- Kullak-Ublick, Gerd A.
- LeCluyse, Edward L.
- Maltman, Daniel J.
- McMullen, Patrick
- Merfort, Irmgard
- Meyer, Christoph
- Mwinyi, Jessica
- Naisbitt, Dean J.
- Nussler, Andreas K.
- Olinga, Peter
- Pampaloni, Francesco
- Pi, Jingbo
- Pluta, Linda
- Przyborski, Stefan A.
- Ramachandran, Anup
- Rogiers, Vera
- Schwarz, Michael
- Singh, Bijay
- Stelzer, Ernst H. K.
- Stieger, Bruno
- Sugiyama, Yuichi
- Vanhaecke, Tamara
- Vinken, Mathieu
- Weiss, Thomas S.
- Woods, Courtney G.
- Hengstler, Jan G.
- Venue
- Archives of Toxicology
- Published
- 2013-08
- Volume
- 87
- Issue
- 8
- Pages
- 1315-1530
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC3753504
- OpenAlex
- W2134520937
- Cited by
- 1,280
- References
- 1,862
- Citations by year
- 2026: 54 · 2025: 63 · 2024: 59 · 2023: 80 · 2022: 98 · 2021: 96 · 2020: 130 · 2019: 132 · 2018: 129 · 2017: 102 · 2016: 118 · 2015: 110 · 2014: 91 · 2013: 12
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Archives of Toxicology (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (submittedVersion, cc-by)
- HAL (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- University of Regensburg Publication Server (University of Regensburg)
- Funders
- Leibniz-Institut für Arbeitsforschung an der TU Dortmund
- Deutsche Forschungsgemeinschaft (GRK1104, (EXC 294))
- Agence Nationale de la Recherche
- Bundesministerium für Bildung und Forschung
- Belgian Federal Science Policy Office
- Fonds Wetenschappelijk Onderzoek
- National Research Foundation of Korea
- Innoviris
- Universität Regensburg
- Vlaamse regering
- National Institutes of Health (AA12916)
- Biotechnology and Biological Sciences Research Council (1233823)
- Leibniz-Gemeinschaft
- Japan Society for the Promotion of Science (23590204)
- National Institute on Alcohol Abuse and Alcoholism (R56AA012916, R01AA012916)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK070195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- hepatotoxicity, primary hepatocytes, non-parenchymal liver cells, hepatocyte co-culture, precision-cut liver slices, isolated perfused liver, stem cell-derived hepatocytes, induced pluripotent stem cell-derived hepatocytes, nuclear receptors, Ras/MEK/ERK pathway, HNF4α, drug metabolism, ADME, drug interactions
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Liver, Inactivation, Metabolic, Organ Culture Techniques, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Toxicity Tests, Coculture Techniques, Hepatocytes, Toxicogenetics, Culture Techniques, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review